← FDA DRUG APPROVALS

FDA NDA · NDA019006

ISOLYTE S PH 7.4 IN PLASTIC CONTAINER

Sponsor: B BRAUN

APPLICATION
NDA019006
TYPE
NDA
ORIGINAL APPROVAL
1984-04-02
LATEST ACTION
1990-09-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ISOLYTE S PH 7.4 IN PLASTIC CONTAINERDiscontinued
MAGNESIUM CHLORIDE 30MG/100ML, POTASSIUM CHLORIDE 37MG/100ML, POTASSIUM PHOSPHATE, MONOBASIC 0.82MG/100ML, SODIUM ACETATE 370MG/100ML, SODIUM CHLORIDE 530MG/100ML, SODIUM GLUCONATE 500MG/100ML, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 12MG/100ML · INJECTABLE · INJECTION

Approval history

1990-09-11Manufacturing (CMC) · Supplement 4 · standardAP
1985-09-18Manufacturing (CMC) · Supplement 1 · standardAP
1984-04-02Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →